Related references
Note: Only part of the references are listed.Synthesis and evaluation of a novel adapter lipid derivative for preparation of cyclic peptide-modified PEGylated liposomes: Application of cyclic RGD peptide
Naoya Kato et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
Synthesis and pharmacokinetic characterisation of a fluorine-18 labelled brain shuttle peptide fusion dimeric affibody
Takahiro Morito et al.
SCIENTIFIC REPORTS (2021)
Rethinking CRITID Procedure of Brain Targeting Drug Delivery: Circulation, Blood Brain Barrier Recognition, Intracellular Transport, Diseased Cell Targeting, Internalization, and Drug Release
Shaobo Ruan et al.
ADVANCED SCIENCE (2021)
B3Pdb: an archive of blood-brain barrier-penetrating peptides
Vinod Kumar et al.
BRAIN STRUCTURE & FUNCTION (2021)
Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy
P. Soma Yasaswi et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Post-capillary venules are the key locus for transcytosis-mediated brain delivery of therapeutic nanoparticles
Krzysztof Kucharz et al.
NATURE COMMUNICATIONS (2021)
ANG1005, a Brain-Penetrating Peptide-Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases
Priya Kumthekar et al.
CLINICAL CANCER RESEARCH (2020)
Brain Targeted Gold Liposomes Improve RNAi Delivery for Glioblastoma
Nilmary Grafals-Ruiz et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Development of Nano-DDS Carriers for Control of Spatial Distribution Using Multi-color Deep Imaging
Shigeru Kawakami et al.
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN (2020)
Recent Strategies for Targeted Brain Drug Delivery
Koki Ogawa et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2020)
Conjugation of Therapeutic PSD-95 Inhibitors to the Cell-Penetrating Peptide Tat Affects Blood-Brain Barrier Adherence, Uptake, and Permeation
Mie Kristensen et al.
PHARMACEUTICS (2020)
A pH-Adjustable Tissue Clearing Solution That Preserves Lipid Ultrastructures: Suitable Tissue Clearing Method for DDS Evaluation
Shintaro Fumoto et al.
PHARMACEUTICS (2020)
A trip of peptides to the brain
Toshiro Matsui et al.
FOOD PRODUCTION PROCESSING AND NUTRITION (2020)
Comparison of organ-specific endothelial cells in terms of microvascular formation and endothelial barrier functions
Hiroyuki Uwamori et al.
MICROVASCULAR RESEARCH (2019)
Synthesis of high functionality and quality mannose-grafted lipids to produce macrophage-targeted liposomes
Masayori Hagimori et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Efficient gene transfection to the brain with ultrasound irradiation in mice using stabilized bubble lipopolyplexes prepared by the surface charge regulation method
Koki Ogawa et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Development of High-Functionality and -Quality Lipids with RGD Peptide Ligands: Application for PEGylated Liposomes and Analysis of Intratumoral Distribution in a Murine Colon Cancer Model
Tadaharu Suga et al.
MOLECULAR PHARMACEUTICS (2018)
Apolipoprotein E Peptide-Directed Chimeric Polymersomes Mediate an Ultrahigh-Efficiency Targeted Protein Therapy for Glioblastoma
Yu Jiang et al.
ACS NANO (2018)
Ligand peptide-grafted PEGylated liposomes using HER2 targeted peptide-lipid derivatives for targeted delivery in breast cancer cells: The effect of serine-glycine repeated peptides as a spacer
Tadaharu Suga et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Blood-brain barrier shuttle peptides: an emerging paradigm for brain delivery
Benjami Oller-Salvia et al.
CHEMICAL SOCIETY REVIEWS (2016)
Progress and perspectives on targeting nanoparticles for brain drug delivery
Huile Gao
ACTA PHARMACEUTICA SINICA B (2016)
Enhanced blood-brain barrier penetration and glioma therapy mediated by a new peptide modified gene delivery system
Hui Yao et al.
BIOMATERIALS (2015)
Cargo Delivery into the Brain by in vivo identified Transport Peptides
Eduard Urich et al.
SCIENTIFIC REPORTS (2015)
Liposomes bi-functionalized with phosphatidic acid and an ApoE-derived peptide affect Aβ aggregation features and cross the blood-brain-barrier: Implications for therapy of Alzheimer disease
Laura Bana et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2014)
Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle
Jens Niewoehner et al.
NEURON (2014)
Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)
Pieter J. Gaillard et al.
PLOS ONE (2014)
Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier
Daren Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier
Jessica A. Couch et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Surface Engineering of Liposomes for Stealth Behavior
Okhil Nag et al.
Pharmaceutics (2013)
The hCMEC/D3 cell line as a model of the human blood brain barrier
Babette Weksler et al.
FLUIDS AND BARRIERS OF THE CNS (2013)
Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies
Daniela E. Eigenmann et al.
FLUIDS AND BARRIERS OF THE CNS (2013)
Analysis of cause of failure of new targeting peptide in PEGylated liposome: Molecular modeling as rational design tool for nanomedicine
Julia Lehtinen et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
A high-affinity, dimeric inhibitor of PSD-95 bivalently interacts with PDZ1-2 and protects against ischemic brain damage
Anders Bach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Micelle-Based Brain-Targeted Drug Delivery Enabled by a Nicotine Acetylcholine Receptor Ligand
Changyou Zhan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2011)
Comparison of five different targeting ligands to enhance accumulation of liposomes into the brain
Inge van Rooy et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model
Francesca Re et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Direct labeling and visualization of blood vessels with lipophilic carbocyanine dye DiI
Yiwen Li et al.
NATURE PROTOCOLS (2008)
Identification and design of peptides as a new drug delivery system for the brain
Michel Demeule et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
An apolipoprotein E-derived peptide mediates uptake of sterically stabilized liposomes into brain capillary endothelial cells
I Sauer et al.
BIOCHEMISTRY (2005)
New insights into the heparan sulfate proteoglycan-binding activity of apolipoprotein E
CP Libeu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Receptor mediated uptake of peptides that bind the human transferrin receptor
JH Lee et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy
C Rousselle et al.
MOLECULAR PHARMACOLOGY (2000)
Share Paper
